BioParathyroid (Bonothyrk) Product Details
BioParathyroid (A-21) features natural parathyroid gland peptides that support calcium and phosphate regulation in the body. These minerals, balanced by healthy parathyroid function, are necessary components for proper nervous system signaling and musculoskeletal structure maintenance.
Contains 20 or 60 capsules: 10-day course or 30-day course
BioParathyroid® is the parathyroid peptide bioregulator (Bonothyrk)
Serves the same role as peptide bioregulators developed naturally in the body
May reduce peptide deficiency
May restore protein synthesis inside cells
Natural Peptides Combinations (Cytomaxes)
Product Facts
Serving Size: 1 Capsule (0.2 g)
Amount Per Serving: Peptide complex A-21 (parathyroid glands peptides) 0.04 g †
Other ingredients: microcrystalline cellulose (E460, flowing agent); calcium stearate (E470, emulsifier)
Capsule: hydroxypropylmethylcellulose
GLUTEN FREE
NON GMO
† Daily Value not established
Key Functions of BioParathyroid® Parathyroid Peptide Bioregulator
Clinical research reveals that BioParathyroid (A-21):
Supports healthy calcium and phosphate levels in the body
Promotes normal parathyroid gland function and metabolism
May help inhibit the development of atrophic processes in parathyroid tissue
Contributes to bone health and may support those with osteoporosis
Designed to assist with muscle function and strength
Supports the body’s natural peptide-protein cycle in parathyroid cells
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Suggested Use
Recommended research applications include:
Contraindications: Individual component sensitivity, pregnancy, breastfeeding
Storage conditions: Store in a dry, dark place at temperatures between +2°C and +25°C
Shelf life: 3 years from production date
Application recommendations: For adult men, take 1-2 capsules, 1-2 times daily with meals
Package quantity: One-month supply




Reviews
There are no reviews yet.